TABLE 2.

Topical superfusion of cromakalim or minoxidil sulfate decreased volumetric lymph flow in rat mesenteric LVs in vivo

Increasing log conc. of cromakalim or minoxidil sulfate (0.01–10 μmol/l) progressively decreased positive volumetric lymph flow compared with the DMSO solvent control (*P < 0.05, mean ± S.D., n = 5).

KCO	Conc. (µmol/l)	Positive Volumetric Flow (% Baseline)
Cromakalim	0.01	121.2 ± 42.4
	0.1	50.6 ± 22.0*
	1	48.6 ± 23.3*
Minoxidil sulfate	0.01	99.7 ± 29.8
	0.1	85.6 ± 13.6
	1	46.4 ± 6.3*
DMSO	2.82	121.2 ± 49.2
	28.16	121.9 ± 55.9
	281.58	136.0 ± 65.8